H&M shares tumble 8% immediately after weaker profits and surprise CEO exit

H&M shares tumble 8% immediately after weaker profits and surprise CEO exit


Folks passing a significant scale signal for the large road clothing and clothes model H&M outside the house their flagship retail outlet on the corner of Oxford Road and Regent Avenue. on 30th March 2023 in London, United Kingdom.

Mike Kemp | In Photographs | Getty Visuals

Shares of Swedish retailer H&M ended up down 8% at 09:05 a.m. London time on Wednesday, right after the firm introduced weaker product sales and the shock departure of its chief executive.

H&M gross sales were being 1% lower for 2023 in nearby currencies, and 4% lower year-on-12 months in the fourth quarter.

In an unpredicted leadership shake-up, previous CEO Helena Helmersson, who has been in the part for four years, will be changed by Daniel Ervér.

In a assertion, Helmersson mentioned she was stepping down with “blended thoughts” and was very pleased of how the firm navigated the pandemic and geopolitical troubles.

“Having said that, it has been pretty demanding at periods for me individually,” she claimed.

Ervér is at present the head of the H&M Brand and has been at the corporation for 18 a long time.

Inventory Chart IconInventory chart icon

hide content

H&M share selling price.



Supply

Bank of America picks five stocks with more room to run after earnings
World

Bank of America picks five stocks with more room to run after earnings

Bank of America named several stocks that are well positioned following earnings. The Wall Street investment bank says companies like Palantir are too attractive to ignore. Other buy-rated names screened by CNBC Pro include: Wayfair , Intapp , Diamondback and AerCap Holdings. Wayfair The online home furnishing company is firing on all cylinders, the firm […]

Read More
Metsera accepts Pfizer’s  billion bid in ongoing M&A battle
World

Metsera accepts Pfizer’s $10 billion bid in ongoing M&A battle

Smith Collection | Archive Photos | Getty Images Obesity drug developer Metsera said on Friday that it had accepted Pfizer‘s $10 billion acquisition offer, in what could spell the end of a bidding war between the New York-based pharma giant and rival Novo Nordisk that erupted over the last week. Pfizer had appeared to have […]

Read More
U.S. grants Hungary exemption on Russia sanctions after warm Trump-Orban meeting
World

U.S. grants Hungary exemption on Russia sanctions after warm Trump-Orban meeting

Hungary’s Prime Minister Viktor Orban attends a bilateral lunch hosted by U.S. President Donald Trump, at the White House in Washington, D.C., U.S., Nov. 7, 2025. Jonathan Ernst | Reuters The United States has granted Hungary a one-year exemption from U.S. sanctions for using Russian oil and gas, a White House official said on Friday, […]

Read More